KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-160.23M
↓ 136% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-68.03M
Historical baseline
PeriodValueYoY Change
TTM$-160.23M-4.8%
2025$-152.91M-71.4%
2024$-89.23M-18.6%
2023$-75.26M+3.7%
2022$-78.13M-159.0%
2021$-30.17M+32.7%
2020$-44.82M-23.2%
2019$-36.37M-444.4%
2018$10.56M+144.5%
2017$-23.72M-